Cargando…

Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs

Experimental evidence suggests that antiangiogenic therapy gives rise to a transient window of vessel normalization, within which the efficacy of radiotherapy and chemotherapy may be enhanced. Preclinical experiments that measure components of vessel normalization are invasive and expensive. We have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutchinson, LG, Mueller, H‐J, Gaffney, EA, Maini, PK, Wagg, J, Phipps, A, Boetsch, C, Byrne, HM, Ribba, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192995/ https://www.ncbi.nlm.nih.gov/pubmed/27863175 http://dx.doi.org/10.1002/psp4.12142

Ejemplares similares

Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings
por: Wilson, S, et al.
Publicado: (2015)

Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level
por: Hutchinson, Lucy, et al.
Publicado: (2019)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
por: Harris, Emily M., et al.
Publicado: (2018)

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma
por: Ouerdani, A, et al.
Publicado: (2015)

Oscillatory dynamics in a model of vascular tumour growth - implications for chemotherapy
por: Stamper, IJ, et al.
Publicado: (2010)

Use of Antiangiogenic Therapies in Pediatric Solid Tumors
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors
por: Indraccolo, Stefano, et al.
Publicado: (2016)

Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
por: Holtz, David O, et al.
Publicado: (2008)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature
por: Torrado, Carlos, et al.
Publicado: (2023)

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
por: Kashyap, Abhishek S., et al.
Publicado: (2020)

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
por: Zarrin, Bahare, et al.
Publicado: (2017)

Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis
por: Lim, Haet Nim, et al.
Publicado: (2018)

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
por: Hu, Haoyue, et al.
Publicado: (2022)

Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
por: Pellerino, Alessia, et al.
Publicado: (2023)

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
por: Vo, Kieuhoa T., et al.
Publicado: (2016)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
por: Ebos, John ML, et al.
Publicado: (2014)

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
por: de Bernardi, Axel, et al.
Publicado: (2022)

Preclinical multimodality phantom design for quality assurance of tumor size measurement
por: Lee, Yongsook C, et al.
Publicado: (2011)

Prevalence of obesity and body size perceptions in urban and rural Senegal: new insight on the epidemiological transition in West Africa
por: Macia, Enguerran, et al.
Publicado: (2017)

Diffusion-Weighted MRI Is Insensitive to Changes in the Tumor Microenvironment Induced by Antiangiogenic Therapy()()
por: Hauge, Anette, et al.
Publicado: (2018)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Radioprotective and tumor antiangiogenic effect of the novel synthetic superoxide dismutase (SOD) mimetic compounds
por: Vujaskovic, Z, et al.
Publicado: (2001)

The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation
por: Nguyen, Ngoc-Quynh-Nhu, et al.
Publicado: (2011)

Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI
por: Zhu, Wenlian, et al.
Publicado: (2014)

Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy
por: Zhang, Li, et al.
Publicado: (2015)

Antiangiogenic Therapy Using Sunitinib Combined with Rapamycin Retards Tumor Growth But Promotes Metastasis()
por: Yin, Tao, et al.
Publicado: (2014)

Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature
por: Li, Qing, et al.
Publicado: (2017)

TARBP2 promotes tumor angiogenesis and metastasis by destabilizing antiangiogenic factor mRNAs
por: Zhou, Meicen, et al.
Publicado: (2021)

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
por: Devapatla, Bharat, et al.
Publicado: (2015)

Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
por: Yonucu, Sirin, et al.
Publicado: (2017)

Tumor Purity in Preclinical Mouse Tumor Models
por: Qian, Wubin, et al.
Publicado: (2022)

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model
por: Veinalde, Rūta, et al.
Publicado: (2023)

Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography
por: Demidov, Valentin, et al.
Publicado: (2018)

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023)

Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters
por: Kim, Cherry, et al.
Publicado: (2018)

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics
por: Mazzocco, P, et al.
Publicado: (2015)

Multimodality Multiparametric Imaging of Early Tumor Response to a Novel Antiangiogenic Therapy Based on Anticalins
por: Meier, Reinhard, et al.
Publicado: (2014)

Antiangiogenic Therapy Impedes Infiltration by CD4+ and CD8+ Cells Into an Early Colon Tumor
por: Yang, Yoon Jung, et al.
Publicado: (2015)

Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells
por: Otsubo, Tsuguteru, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_37djhk5hg7bq2u6qr5u70ebkas